2-BROMO-5-FLUOROANILINE structure
|
Common Name | 2-BROMO-5-FLUOROANILINE | ||
---|---|---|---|---|
CAS Number | 1003-99-2 | Molecular Weight | 190.013 | |
Density | 1.7±0.1 g/cm3 | Boiling Point | 228.2±20.0 °C at 760 mmHg | |
Molecular Formula | C6H5BrFN | Melting Point | 43-47 °C(lit.) | |
MSDS | Chinese USA | Flash Point | 91.8±21.8 °C | |
Symbol |
GHS07 |
Signal Word | Warning |
Name | 2-Bromo-5-fluoroaniline |
---|---|
Synonym | More Synonyms |
Density | 1.7±0.1 g/cm3 |
---|---|
Boiling Point | 228.2±20.0 °C at 760 mmHg |
Melting Point | 43-47 °C(lit.) |
Molecular Formula | C6H5BrFN |
Molecular Weight | 190.013 |
Flash Point | 91.8±21.8 °C |
Exact Mass | 188.958939 |
PSA | 26.02000 |
LogP | 2.58 |
Vapour Pressure | 0.1±0.5 mmHg at 25°C |
Index of Refraction | 1.597 |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H315-H319-H335 |
Precautionary Statements | P261-P305 + P351 + P338 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
Hazard Codes | Xi:Irritant; |
Risk Phrases | R36/37/38 |
Safety Phrases | S26-S36 |
RIDADR | UN2811 |
WGK Germany | 3 |
Packaging Group | III |
Hazard Class | 6.1 |
HS Code | 2921420090 |
~99% 2-BROMO-5-FLUOR... CAS#:1003-99-2 |
Literature: Bristol-Myers Squibb Company Patent: US2007/259850 A1, 2007 ; Location in patent: Page/Page column 95-96 ; US 20070259850 A1 |
~81% 2-BROMO-5-FLUOR... CAS#:1003-99-2 |
Literature: Pagoti, Sreenivasarao; Surana, Subham; Chauhan, Ajay; Parasar, Bibudha; Dash, Jyotirmayee Catalysis Science and Technology, 2013 , vol. 3, # 3 p. 584 - 588 |
~11% 2-BROMO-5-FLUOR... CAS#:1003-99-2 |
Literature: Synthesis, , # 8 art. no. P12608SS, p. 1305 - 1308 |
~% 2-BROMO-5-FLUOR... CAS#:1003-99-2 |
Literature: Bioorganic and Medicinal Chemistry, , vol. 11, # 23 p. 5259 - 5272 |
~% 2-BROMO-5-FLUOR... CAS#:1003-99-2 |
Literature: Angewandte Chemie - International Edition, , vol. 50, # 51 p. 12257 - 12261 |
Precursor 5 | |
---|---|
DownStream 7 | |
HS Code | 2921420090 |
---|---|
Summary | HS:2921420090 aniline derivatives and their salts VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate.
Curr. Med. Chem. 11(8) , 1009-21, (2004) This review traces the development of a series of potent and selective antitumour benzothiazoles from the discovery of the initial lead compound, 2-(4-amino-3-methylphenyl)benzothiazole (DF 203) in 19... |
|
Synthesis of isotopically labelled [3-14C]-and [3, 3-2H2]-5-fluoro-1, 3-dihydro-1-hydroxy-2, 1-benzoxaborole (AN2690), a new antifungal agent for the potential treatment of onychomycosis. Baker SJ, et al.
J. Labelled Comp. Radiopharm. 50(4) , 245-250, (2007)
|
|
Synthesis of novel benzylamine analogues of Anacardic acid as potent antibacterial agents. Dubey PK.
Der Pharma Chemica 3(6) , 500-512, (2011)
|
ZR CF FE |
2-bromo-5-fluoro-aniline |
2-Bromo-5-fluoro-phenylamine |
2-bromo-5-fluorobenzeneamine |
2-Bromo-5-fluoroaniline |
MFCD00070750 |
Benzenamine, 2-bromo-5-fluoro- |
benzenamine,2-bromo-5-fluoro |
2-Bromo-5-fluorobenzenamine |
2-BROMO-5-FLUORO-BENZENAMINE |